Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
A new year brings a new therapeutic milestone for weight management: Following i...
The Endocrine Society is pleased to announce its Rare Endocrine Disease (RED) Fe...
Eli Lilly’s “Ozempic-in-a-pill” candidate just cleared its most significant clin...
As the onslaught of anti-obesity drugs hit the market in recent years, more rese...
In the United States, American Heart Month is observed in February to raise awar...
The “black box” warning on the popular diabetes and weight loss drug semaglutide...
The Endocrine Society’s 2026 recipient of the Outstanding Clinical Investigator ...
As the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) expands, so t...
As an endocrine scientist and long-time Society member, I’m proud of the many pr...
